News WrapGet Handpicked Stories from our editors directly to your mailbox


Novartis to buy US gene therapy group AveXis for $8.7 billion

It said the all-cash deal was approved unanimously by the boards of both firms.

Apr 09, 2018, 12:17 PM IST

GSK buys Novartis stake in consumer healthcare venture for $13 billion

The deal is set to complete in the second quarter subject to the necessary approvals.

Mar 27, 2018, 14:37 PM IST

US approves first gene therapy for cancer

Gene therapy is a treatment that uses a patient`s own immune cells to fight leukemia.

Aug 30, 2017, 22:50 PM IST

Sun Pharma to acquire oncology product from Novartis for $175 million

Drug major Sun Pharmaceutical Industries on Thursday said it it will acquire a branded oncology product, Odomzo, from Novartis for an upfront payment of USD 175 million.

Dec 22, 2016, 11:21 AM IST

Sniff your way to `slimmer` you with `love hormone` spray

Results in 10 overweight and obese men suggest that one way oxytocin lowers food intake might be by improving self-control, said co-investigator Franziska Plessow of the Massachusetts General Hospital, Boston.

Apr 03, 2016, 11:13 AM IST

NeoBiocon to sell anti-diabetic drug in UAE

Vildagliptin is available as monotherapy and in combination with metformin. Both the drugs commands over 30 percent of the DPP-IV market in the UAE.

Dec 10, 2015, 20:47 PM IST

Antim Baazi: NeoBiocon Partners with Novartis

NeoBiocon Partners with Novartis which shows good momentum in Biocon intra-day trading.

Dec 09, 2015, 19:38 PM IST

US fines Novartis $390 million over pharmacy kickbacks

Novartis admitted that it gave specialty pharmacies exceptional rebates and patient referrals in exchange for recommending Exjade.

Nov 21, 2015, 05:01 AM IST

Novartis India gets FIPB nod to sell OTC biz to GSK CPL

The Foreign Investment Promotion Board (FIPB) has approved the proposal made by GSK CPL to acquire the company's OTC division, Novartis India said in a BSE filing.

Aug 28, 2015, 19:32 PM IST

Sandoz Inc recalls India-made anti-allergic tablets in US

Drug firm Sandoz Inc is recalling India-made 1,023,430 units of anti-allergic Cetirizine HCl chewable tablets in the US due to impurity concerns.

Jun 11, 2015, 17:38 PM IST

New-look GSK bets on consumer health spending

GSK predicted on Wednesday its consumer health sales would grow at a mid-single-digit compound annual rate over the next five years, slightly ahead of overall company sales.

May 06, 2015, 17:06 PM IST

Novartis warns of currency drag on 2015 earnings

Swiss drugmaker Novartis on Thursday posted declining sales in the first quarter and cautioned that dollar strength may be a bigger-than-expected drag on full-year figures.

Apr 23, 2015, 13:02 PM IST

Novartis Japan hit with suspension over side-effect reporting

Japanese health authorities said Friday that they have ordered the local unit of Swiss pharmaceutical giant Novartis to temporarily suspend its operations for failing to report drug side effects.

Feb 27, 2015, 21:16 PM IST

GSK Pharma to transfer cancer drug portfolio to Novartis arm

GlaxoSmithKline Pharmaceuticals board on Thursday approved transfer of its cancer drugs portfolio to an arm of Novartis in India in return for acquiring vaccines portfolio as part of a global deal between the two-multinational pharma giants struck last year.

Feb 12, 2015, 21:59 PM IST

Novartis Q3 net loss at Rs 1.18 crore

Drug firm Novartis India Ltd on Wednesday reported a net loss of Rs 1.18 crore for the third quarter ended December 31, 2014.

Feb 04, 2015, 20:43 PM IST

EU puts conditions on deals involving Novartis, GSK

The European Union on Wednesday approved mega deals involving drugmakers Novartis of Switzerland and GlaxoSmithKline of Britain, provided they sell off assets in the vaccines and consumer health businesses.

Jan 29, 2015, 00:14 AM IST

Novartis profits jump 12% on new drug sales

Swiss pharmaceuticals giant Novartis said Tuesday strong sales of new products helped push its net profit up 12 percent last year despite harsh competition from cheaper copycat generic drugs.

Jan 27, 2015, 16:17 PM IST

HC order 'disappointing', says Cipla

Drug maker Cipla Friday expressed disappointment over the Delhi High Court order that restrained the company from manufacturing and selling any medicine containing 'Indacaterol', saying that the interim verdict would deny patients access to drugs they need.

Jan 09, 2015, 23:10 PM IST

Japan first nation to approve Novartis psoriasis drug

Swiss pharmaceutical company Novartis said today it has won approval to market its Cosentyx psoriasis treatment in Japan, making it the first country to authorise commercialisation of the drug.

Dec 26, 2014, 21:58 PM IST

Novartis shares up nearly 2% at close

Surrendering most of early gains in-line with a weak stock market, shares of Novartis India ended nearly 2 percent higher Wednesday, a day after fair trade regulator CCI approved a multi-billion dollar deal between global pharma giants GlaxoSmithKline Plc and Novartis.

Dec 24, 2014, 13:59 PM IST